康龙化成 (300759.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

27.8x

EV/EBITDA

25.4x

Market Cap

CNY 82.42B

MomentumView details →

1D Return

−6.50%

YTD Return

+44.88%

RSI (14)

44.5

ValuationView details →

P/E (Fwd)

27.8x

EV/EBITDA

25.4x

Market Cap

CNY 82.42B

RSI (14)

44.5

MomentumView details →

1D Return

−6.50%

YTD Return

+44.88%

ProfitabilityView details →

Gross Margin

34.51%

Net Margin

11.62%

EBITDA Margin

20.87%

ROE (TTM)

10.29%

ROA (TTM)

5.93%

Asset Turnover

0.52x

GrowthView details →

Revenue YoY

+14.73%

EPS YoY

−9.34%

FCF YoY

−52.20%

Revenue CAGR 3Y

+11.14%

EPS CAGR 3Y

+6.81%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

CNY 0.23

EPS Surprise

−4.16%

Beats (12Q)

0/12

Next Q EPS Est

CNY 0.29

Avg Surprise (4Q)

−4.16%

Rev Surprise

−0.06%

Capital & dividendView details →

Debt/Equity

0.21x

Current Ratio

1.08x

Quick Ratio

0.88x

Div Yield

0.49%

Div Rate

CNY 0.20

Div Growth 1Y

+0.00%

Financials snapshotView financials →

Revenue (TTM)

14.57B

Net Income (TTM)

1.69B

Op. CF (TTM)

2.97B

Next earningsOct 22, 2026 →

Latest newsMore news →

Pharmaceutical R&D service company Pharmaron (03759) announced the proposed issuance of RMB 2.18 billion zero-coupon convertible bonds due 2027, priced at 102% of principal, with net proceeds of approximately USD 327.2 million to be used for business expansion, debt refinancing, and general corporate purposes.9d ago

AI² Robotics and Pharmaron signed a strategic partnership agreement to combine AI² Robotics' embodied large model technology with Pharmaron's life sciences expertise, focusing on deploying embodied intelligence in pharmaceutical R&D and building smart lab ecosystems.10d ago

Similar companies

泰格医药300347.SZ 华测检测300012.SZ 富乐德301297.SZ 南网能源003035.SZ 华大基因300676.SZ 百普赛斯301080.SZ Find similar companies →

Latest newsMore news →

Pharmaceutical R&D service company Pharmaron (03759) announced the proposed issuance of RMB 2.18 billion zero-coupon convertible bonds due 2027, priced at 102% of principal, with net proceeds of approximately USD 327.2 million to be used for business expansion, debt refinancing, and general corporate purposes.9d ago AI² Robotics and Pharmaron signed a strategic partnership agreement to combine AI² Robotics' embodied large model technology with Pharmaron's life sciences expertise, focusing on deploying embodied intelligence in pharmaceutical R&D and building smart lab ecosystems.10d ago